SCHEMBL19976767

SCHEMBL19976767

CC(C)CN/C(=N/C(=O)c1ccc(F)c(F)c1)Nc1n[nH]c2cc(C(F)(F)F)ccc12

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.51
TRPA1 O75762 3/20 0.48
HDAC6 Q9UBN7 6/20 0.46
MAPK1 P28482 3/20 0.42
MAP2K4 P45985 1/20 0.42
MAPK6 Q16659 1/20 0.42
MAPKAPK5 Q8IW41 1/20 0.42
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
MAPK8 P45983 1/20 0.38
MAPK10 P53779 1/20 0.38
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976854 0.93 GSK3B (0.42) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL19976729 0.93 HDAC6 (0.49) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL19976776 0.89 GSK3B (0.48) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL19976769 0.89 GSK3B (0.51) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL19976888 0.88 GSK3B (0.51) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL19976846 0.87 KDM4E (0.42) GSK3BHDAC6MAPK1MAPKAPK5MAPK8
SCHEMBL19976725 0.86 GSK3B (0.52) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL19976812 0.86 GSK3B (0.51) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL16752809 0.85 GSK3B (0.48) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL16752808 0.85 GSK3B (0.48) GSK3BTRPA1HDAC6MAPK1MAP2K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed